Tula, Russian Federation Clinical Trials

A listing of Tula, Russian Federation clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 26 clinical trials
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199) With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL

The purpose of this study is to evaluate the efficacy and safety of acalabrutinib in combination with venetoclax and acalabrutinib in combination with venetoclax with and without obinutuzumab compared to chemoimmunotherapy in subjects with previously untreated CLL.

obinutuzumab
acp-196
abt-199
fludarabine
venetoclax
Research Site
 (3.4 away) Contact site
  • 342 views
  • 31 May, 2021
  • +243 other locations
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

Myelofibrosis is a type of bone marrow cancer that usually develops slowly and disrupts body's normal production of blood cells. It causes bone marrow scarring, leading to severe anemia that can cause weakness and fatigue. It can also cause a low number of blood-clotting cells called platelets, which increases risk …

Tula Regional Clinical Hospital /ID# 221027
 (3.4 away) Contact site
  • 0 views
  • 28 Apr, 2021
  • +106 other locations
Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma

This study will evaluate the efficacy and safety of belantamab mafodotin in combination with pomalidomide and dexamethasone (Arm A) compared with that of combination of pomalidomide, bortezomib and dexamethasone (Arm B) in participants with relapsed/refractory multiple myeloma (RRMM).

dexamethasone
pomalidomide
measurable disease
bortezomib
refractory multiple myeloma
GSK Investigational Site
 (3.4 away) Contact site
  • 0 views
  • 26 Jul, 2021
  • +73 other locations
Double-blind Randomized Placebo-controlled Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients with Chronic Lymphocytic Leukemia

primary infection
igiv
chronic lymphocytic leukemia
Octapharma Research Site
 (3.4 away) Contact site
  • 0 views
  • 23 Jul, 2021
  • +37 other locations
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

stemi
diabetes
myocardial infarction
arterial disease
stroke
6430043 - Tula Regional Clinical Hospital
 (3.4 away) Contact site
  • 1118 views
  • 04 Aug, 2021
  • +3430 other locations
DISCOVER iCaReMe Global Registry

To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, chronic kidney disease and heart failure

heart failure
diabetes
Research Site
 (30.4 away) Contact site
  • 593 views
  • 08 Jul, 2021
  • +128 other locations